Categories
Pharmaceutical

Global Oral Antivirals Market to Offer Increased Growth Prospects for Manufacturers

According to Fact.MR, key players are actively focusing on novel drug development for HIV to improve the drug effects on the patients suffering from HIV. Increasing research and development (R&D) activities for the improvement of nucleoside reverse transcriptase inhibitors drugs such as zidovudine, iamivudine and more has improved the demand of oral antivirals. According to the study of World Health Organization, in 2020, around 38 million people across the globe were recorded with HIV and among those 1.8 million were children. Acknowledging this burden, healthcare professionals have increased the R&D activities for the drug development.

The demand for oral antiviral has been steadily rising as the coronavirus pandemic induced away towards protection and hygiene. To cater for the growing demand for antivirals, the leading manufacturers and the merging players have started to kick the opportunities to tackle the pandemic crisis and shape their position in the competitive oral antivirals market. Government support and manufacturers investment to develop safe and effective novel formulation has projected growth in demand for antivirals in the oral antivirals market.

Request a Sample Report containing crucial Graphs and Figures: https://www.factmr.com/connectus/sample?flag=B&rep_id=5613

Key Segments of global oral antivirals market Covered in the Report

Based on type, the oral antivirals market has been segmented as

  • Generic
  • Branded

Based on drug class, the oral antivirals market has been segmented as

  • Nucleoside reverse transcriptase inhibitors (NRTI)
  • Neuraminidase inhibitor
  • Nucleoside analogues of guanine
  • Nucleoside analogues of thymidine
  • Protease Inhibitors
  • Nucleotide reverse transcriptase inhibitor (NtRTI)
  • Combination Drugs
  • Others

Based on disease indication, the oral antivirals market has been segmented as

  • Influenza
  • Hepatitis
  • Human Immunodeficiency Virus (HIV)
  • Coronavirus
  • Others

Based on distribution channel, the oral antivirals market has been segmented as

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Request Customized Report as Per Your Requirements : https://www.factmr.com/connectus/sample?flag=B&rep_id=5613

Competitive Landscape

Key players such as

  • Novartis AG
  • Abbvie Inc.
  • GlaxoSmithKline
  • Merck & Co.Inc.
  • Bristol-Myers Squibb Company
  • Mylan N.V.
  • Gilead Sciences Inc.
  • Janssen Pharmaceuticals Inc.
  • Appili Therapeutics
  • Boston biotech Atea Pharmaceutical
  • others

Essential Takeaways from the Oral Antivirals Market Report

  • Comparison of prominent players operating in the Oral Antivirals market
  • Recent developments and key strategies adopted by market players
  • Study of the micro and macro-economic growth indicators
  • Impact of the various factors on the value chain of the Oral Antivirals market
  • Growth opportunities for emerging market players in various regional markets
  • Current trends influencing the scenario of the Oral Antivirals market

Important queries related to the Oral Antivirals market addressed in the report:

  • Who are the most prominent players in the Oral Antivirals market?
  • What are the factors that are likely to hinder the growth of the Oral Antivirals market during the forecast period?
  • Why is the concentration of tier-1 companies high in specific region?
  • How are the soaring prices of raw materials impacting the demand for Oral Antivirals?
  • Why are market players eyeing opportunities in particular region?

Browse More Reports by Fact.MR: https://www.biospace.com/article/covid-pandemic-and-chronic-breathing-disorders-are-biggest-driving-factors-for-hyperinflation-system-market-observes-fact-mr

Explore Fact.MR’s Coverage on the Healthcare Domain

Oral & Topical Anesthetics Market: A latest study by Fact.MR on the oral & topical anesthetics market offers an in-depth evaluation on the opportunities and trends through 2021 and beyond. The study scrutinizes crucial trends that are currently shaping market growth.

Oral Thin Films Market: Fact.MR provides a detailed valuation of oral thin films market value chain analysis, business execution, and supply chain analysis across regional markets that has been provided in the report

Extended Oral Antibiotics Market: Fact.MR delivers an in-depth analysis on global extended oral antibiotics market with the strategies and competitive landscape through 2021 and beyond.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand Share Analysis of Intranasal migraine drugs over the Assessment Period of Next 10 Years

The study on the global intranasal migraine drugs market published by Fact.MR is a comprehensive analysis of the key factors that are likely to determine the growth of the intranasal migraine drugs market in the upcoming years. Further, the study dives deep to investigate the micro and macro-economic parameters that are expected to influence the global scenario of the Intranasal migraine drugs market during the forecast period (2021-2031). The report examines the current trends, growth opportunities, restraints, and market drivers that are projected to influence the overall dynamics of the intranasal migraine drugs market in the assessment period. The survey report provides a comprehensive analysis of intranasal migraine drugs market key trends and insights on intranasal migraine drugs market size and share.

To Remain ‘Ahead’ Of Your Competitors, Request For A Brochure : https://www.factmr.com/connectus/sample?flag=B&rep_id=5612

Headache is a typical verbose problem, the sign of which is a debilitating migraine for the most part connected with sickness, as well as light and sound affectability. The intense therapy of headache in grown-ups is audited here. Preventive treatment of headache in grown-ups is examined independently. Headache cerebral pains are genuinely normal in everyone: 17.6 percent of ladies and 5.7 percent of men have at least one headache migraines each year. Intranasal drugs are a significant piece of treatment for migraine, on account of the verbose idea of headache assaults, treatment choices that quickly and viably limit torment are required.

Key Segments of Intranasal migraine drugs market Covered in the Report

Based on Intranasal migraine drugs Market, By Therapeutic class:

  • Corticosteroids
  • NSAID’S
  • Opioids
  • Antibiotics
  • Local Anaesthesia
  • Antihistamines

Based on Intranasal migraine drugs Market, By Indication:

  • Common Migraine
  • Classic Migraine
  • Cluster Migraine
  • Others

Based on Intranasal migraine drugs Market, By Range:

  • Broad spectrum/ Chronic
  • Narrow spectrum/ Acute

Intranasal migraine drugs Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Third party manufacturing companies

Request Customized Report as Per Your Requirements: https://www.factmr.com/connectus/sample?flag=T&rep_id=5612

Competitive Landscape

Key players such

  • Aegis Therapeutics LLC
  • Neuro Pharma
  • Reddy’s Laboratories
  • Novartis AG
  • Pfizer Inc.
  • Lockhart ltd
  • Roche
  • Sanofi
  • Merck
  • Baxter International Inc.
  • Becton
  • Dickinson and Company
  • GlaxoSmithKline PLC and Johnson & Johnson Inc.

How Insights and Analysis by Fact.MR Make Difference?

The in-depth assessment of various growth dynamics of the intranasal migraine drugs market and insights on market estimations help all market participants to stay ahead in the curve of growth with a worldwide economic impact of COVID-19. Some of the insights that can make the difference are:

  • Most rapidly expanding region and the top revenue-generating region.
  • Trends that are outliers to the historical growth of various regional markets.
  • Products, services, and technologies that will attract sizable research and investment funding by governments of different countries
  • Macroeconomic dynamics that may make a characteristic change in the growth trajectory of the overall Intranasal migraine drugs market.

Read More Trending and Similar Reports from Fact.MR – https://www.prnewswire.com/news-releases/home-diagnostics-market-witnessing-heightened-start-up-investments-offering-specialized-solutions-factmr-301212625.html

Explore Fact.MR’s Coverage on the Healthcare Domain:

Digital Migraine Treatment Device Market: A recent study by Fact.MR on the digital migraine treatment device market offers an unbiased analysis on the opportunities and trends through 2021 and beyond.

High Flow Nasal Cannula Market: Fact.MR gives a detailed assessment of High flow nasal cannula market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

Preclinical Brain Imaging Market: Fact.MR delivers an in-depth analysis on global preclinical brain imaging market with the strategies and competitive landscape through 2021 and beyond.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
 

Categories
Pharmaceutical

Antiseptic and Disinfectant Market will Expand at a Healthy CAGR of ~6% during the forecast period (2021-2026)

Despite the growing popularity of disposable medical products, antiseptic and disinfectant products hold high sales possibilities. Some reusable medical equipment, such as scissors and pliers, require frequent sterilization, which is driving the demand for disinfectants in the healthcare industry. Sales are also projected to gather strength in the hospitality industry to boost customer experience, and, in turn, increase their retention rate. On the development side, ease of receiving FDA approval widens the innovation bandwidth of manufacturers, which is leading to high product efficiency.

Based on a robust research approach, an exclusive study published by Fact.MR projects that, the antiseptic and disinfectant market will expand at a healthy CAGR of ~6% during the forecast period (2020-2026).

Request a report sample to gain comprehensive insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=4330

Reusable surgical equipment such as scissors and pliers require sterilization before being used for surgical operation to avoid the risk of infection and other complications. This is the key factor driving the demand of disinfectants in medical sector.

Increasing government initiatives undertaken to limit the cases of hospital acquired infections along with surge in health conscious population especially in developed countries will create opportunities for market growth.

“Government initiatives undertaken to spread awareness regarding personal hygiene, especially in emerging economies are expected to accelerate the sales of disinfectants and antiseptics during the forecast period,” said a Fact MR analyst.

antiseptic and disinfectant market top segments

Request Antiseptic and Disinfectant Market Customization At:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=4330

Market Players Generate Significant Revenue from Healthcare Facilities

The strong market hold of established players such as 3M Company, Kimberly-Clark, Becton, Dickinson and Company, Cardinal Health, and STERIS PLC turn the antiseptic and disinfectant market oligopolistic in nature. Cardinal Health holds ~48% of the 80% share accounted by leading players. The company primarily relies on established as well as emerging healthcare facilities for revenue generation.

Another leading player, 3M Company, accounts for ~20% of the share held by these players in the antiseptic and disinfectant market, as it is scrambling towards developing countries such as China and India, which hold high sales potential. Besides expansion in overseas territories, the development of sophisticated products for advanced medical devices remains a winning strategy for this player to close sales in developed regions such as North America and Europe.

Expansion of application segments of antiseptic and disinfectant products in the food industry is projected to offer new revenue channels for players in the antiseptic and disinfectant market. On the backdrop of this influence, regional and local players are experimenting with different chemical compositions to develop effective solutions.

Find More Valuable Insights on Antiseptic and Disinfectant Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global antiseptic and disinfectant market, presenting historical demand data (2016-2019) and forecast statistics for the period of 2020-2026. The study divulges compelling insights on the antiseptic and disinfectant market on the basis of product (quaternary ammonium compounds, chlorine compounds, alcohols, aldehydes, phenolic compounds, hydrogen peroxide, iodine, silver, and others) and end user (healthcare providers, commercial users, and domestic users) across five major regions.

Get More Insights – https://www.biospace.com/article/demand-for-antiseptic-and-disinfectants-to-surpass-us-4-bn-in-2021-fact-mr-concludes-in-a-latest-study/

Competitive Landscape

Antiseptic and disinfectant market is highly consolidated due to presence of a large number of regional and international market players. However, the top ten market players account for more than 80% of the global antiseptic and disinfectants market share.

Leading market players are focusing on expanding their overseas ventures and develop modern products for modern medical devices to boost their sales in North America and European market. They are also emphasizing on new product development to exploit the high revenue opportunities offer by emerging economies in Asia.

For instance, Indian Tobacco Company (ITC) launched its new disinfectant spray and liquid cleaner under its Savlon brand, in August 2020. This multipurpose disinfectant cleaner claims to offer dual benefit of cleaning and disinfecting in a single product.

Regional market players are experimenting with different chemical compositions to develop new and effective solutions will boost the market growth.

Key players operating in the antiseptic and disinfectant market are

  • Novartis AG
  • 3M Company
  • Johnson & Johnson
  • STERIS PLC
  • Getinge Group
  • Cardinal Health
  • Becton
  • Dickinson and Company
  • GlaxoSmithKline PLC
  • Kimberly-Clark

 

Explore Fact. MR’s Coverage on the Healthcare Domain

Antiseptic Bathing Market – Antiseptic bathing products are gaining popularity as a way to cleanse the skin before surgery. Due to the existence of a significant number of local competitors in the APAC geography, the antiseptic bathing market remains divided. The antiseptic bathing market’s major firms are focusing their efforts on expanding their antiseptic bathing businesses in emerging areas.

Skin Antiseptic Market – Demand for skin antiseptics in the United States and Canada will be driven by an increase in the number of surgeries conducted, which will have a negative impact on market growth. The surgeon’s initial step before the procedures is a pre-operative skin examination. Injection by application segment is expected to increase steadily over the next few years. The global market for skin antiseptics has been dominated by chlorhexidine gluconate.

Surgical Equipment Market – The advancements in minimally invasive procedures seen in the previous few years are symptomatic of significant advancements in surgical technology. Surgeons have been able to harness their expertise to give increased precision in complex procedures thanks to research and development activities done in recent years. The global surgical equipment market is divided into three categories – portable instruments, surgical sutures and staples, and electrosurgical devices.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/4330/antiseptic-and-disinfectant-market
Press Release: https://www.factmr.com/media-release/1155/global-antiseptic-and-disinfectant-market

Categories
Pharmaceutical

Breast Cancer Diagnostics Market – Hospital-associated Labs to Remain the Largest End-Users, Finds Fact.MR

Award winning market research company Fact.MR has conducted a research study on the global demand of breast cancer diagnostics market for the forecast period of 2021 to 2031. As per its analysis, the market is expected to register a moderate growth, primarily underpinned by the growing cases of breast cancer. Growth prospects for the upcoming decade are also positive, as the market is forecast to register 4.7% CAGR through 2021 and beyond.

According to Fact.MR, the market is poised to benefit immensely on the back of technological advancement in the diagnostic platforms. Introduction of hybrid imaging instruments and the adoption of artificial intelligence in the field is expected to yield positive response for the breast cancer diagnostics market. Furthermore, increasing cases of breast cancer among older female population is augmenting the market growth.

 

Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=55

 

According to U.S. breast cancer statistics for 2021, an estimated 281,500 new cases of invasive breast cancer are expected to be diagnosed in the women within United States, along with 49,290 new cases of non-invasive breast cancer. Additionally, around 3.8 million women were recorded with the history of breast cancer in January 2021. Hence, with rising burden of these new cases, the market is expected to register a steady growth through 2021 and beyond.

 

8 Estimations for the Global Breast Cancer Diagnostics Market
  1. By test type, BRCA will remain dominant in the global breast cancer diagnostics market.
  2. CA test for diagnostics of breast cancer is expected to register the highest CAGR through 2022 in the market, followed by ER & PR. Revenue from ER & PR, and CA tests will continue to be low throughout the forecast period.
  3. HER 2 test is expected to remain the second largest segment among test type, in the market. However, EGFR mutation test is estimated to account for low revenues in the global market for breast cancer diagnostics.
  4. North America will continue to be the largest market for breast cancer diagnostics. Revenues from breast cancer diagnostics market in North America is estimated to surpass US$ 800 Mn by 2022-end.
  5. Europe will remain the second most lucrative region for the breast cancer diagnostics market. However, markets in Japan, and Middle East & Africa (MEA) are anticipated to witness a sluggish expansion throughout the forecast period.
  6. Hospital-associated labs will remain sought-after among end-users for breast cancer diagnostics around the world. Revenues from breast cancer diagnostics will remain largest in hospital-associated labs, followed by the independent diagnostic laboratories.
  7. Cancer research institutes are anticipated to exhibit the highest CAGR during the forecast period. Between 2017 and 2022, cancer research institutes are estimated to create absolute $ opportunity of US$ 107.3 Mn.

 

Request Methodology & Get a Glimpse of Our Expertise
https://www.factmr.com/connectus/sample?flag=RM&rep_id=55

 

Competitive Landscape

Key players operating in the breast cancer diagnostics market profiled by Fact.MR includes Abbott Laboratories, Roche Holding AG, Thermo Fischer Scientific Inc., GE Healthcare, Siemens AG, Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Epigenomics AG, Astra Zeneca PLC, Myriad Genetics Inc. and Quest Diagnostics Incorporated.

On February 22nd 2021, Medifirst Solutions Inc., announced a clinical study for a breast cancer medical device for real-time margin detection to provide direct support during lumpectomy cancer surgery.

Also, in March 2021, Celcuity Inc., a clinical storage biotechnology company announced the breast cancer clinical trial collaboration with MD Anderson, Novartis, and Puma Biotechnology to identify new targeted therapeutic options for cancer patients through new drug study regimen.

Furthermore, Koios Medical Inc., a fast-growing developer of artificial intelligence software for physicians announced the CE Mark approval and European Market Launch on 16th March 2021, for breast cancer detection AI software.

 

Get More Insights – https://www.biospace.com/article/breast-cancer-diagnostics-market-sales-set-to-grow-by-4-7-percent-to-surpass-us-2000-mn-by-2022-end-fact-mr/

 

Explore Fact.MR’s Coverage on the Healthcare Domain

Automated Breast Ultrasound Systems Market: A recent study by Fact.MR on the automated breast ultrasound systems market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Silicone Gel Filled Breast Implant Market: Fact.MR gives a detailed assessment of silicone gel filled breast implant market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Breast Reconstruction Market: Fact.MR delivers an in-depth analysis on global breast reconstruction market with the strategies and competitive landscape through 2021 and beyond. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight:https://www.factmr.com/report/55/breast-cancer-diagnostics-market
Press Release:https://www.factmr.com/media-release/41/breast-cancer-diagnostics-market

Categories
Pharmaceutical

Alexandrite Gemstone Lasers Market to Exhibit 7% CAGR through 2030, Finds Fact.MR

The global demand of alexandrite gemstone lasers market study by Fact.MR projects a steady growth in the upcoming decade. According to the study, the market is expected to have an upward trajectory backed by the rising adoption of aesthetic treatments and increasing consumer awareness in dermatology treatments. Technological advancement and penetration of Artificial Intelligence used in developing real-time projects for the laser treatment procedures of hair and tattoo removal is aiding the market growth.

According to Fact.MR, focus on innovation and research & development (R&D) in advanced technology and upgrading the existing laser devices are improving the demand for enhanced device to necessitate the demand from consumer for non-invasive laser procedures. Furthermore, advancement in laser technologies for various cosmetic treatments such as hair removal, tattoo removal, vascular lesions and others has accelerated the demand through 2021 and beyond.

Request a report sample to gain comprehensive insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=870 

 

In addition, manufacturers in the alexandrite gemstone lasers market are highly engaged in various industry consolidation activities such as mergers, acquisitions, and collaborations to increase their product range and distribution network, which creates huge growth opportunities for the market growth.

  • In June 2018, Alma Lasers completed the acquisition of Vertiflex, Inc., a privately-held company that developed and commercialized the superion indirect decompression system.

According to Fact.MR, the global alexandrite gemstone lasers market is estimated to expand twofold to be valued at US$ 285 Mn by 2030-end.

alexandrite gemstone lasers market

Anticipated Market Impact by COVID-19 Outbreak

The alexandrite gemstone lasers market growth has been affected adversely on the onset of the COVID-19 pandemic. Due to the threat triggered by the pandemic, there has been a substantial drop in demand for these products, across the globe. Laser treatment centers and hospitals have also reflected a slump in demand for alexandrite gemstone lasers processes since the priority at present is fighting the spread of COVID-19.

Request Methodology & Get a Glimpse of Our Expertise
https://www.factmr.com/connectus/sample?flag=RM&rep_id=870

 

Prominent Drivers

  • Increased research & development in advanced technology and refinement in existing laser devices will boost the demand of alexandrite gemstone lasers market
  • Preference for non-invasive treatments for hair and tattoo removal is expected to improve the demand

Key Restraints

  • Excessive cost of the procedure and side-effects associated with the laser procedure is expected to restrict the growth of the market
  • Social stigma and low awareness associated with the cosmetic treatments such as hair removal, tattoo removal and others will hamper the demand
  • Stringent regulatory policies for aesthetic laser procedures is expected to pose a challenge for the market

 

Competition Landscape

Key companies functioning in the global market are Candela, Cynosure, Inc., Alma Lasers, Quanta Systems, Lutronic Corporation, Asclepion Laser Technologies, Lumenis, and Bison Medical. Companies have adopted several strategies such as collaboration with healthcare institutes for the r&d of products, increased competition, and enabling technological advancements in the market.

Get More Insights – https://www.biospace.com/article/alexandrite-gemstone-lasers-market-to-expand-as-demand-for-dermatology-treatment-rises-fact-mr/

 

More on the Report

The Fact.MR’s market research report provides in-depth insights into the Alexandrite Gemstone Lasers market. The market is scrutinized based on indication (hair removal, tattoo removal, vascular lesion, pigmented lesion, and others), application (aesthetic, dermatology, dentistry, urology, and others), and end user (hospitals, laser treatment centers, specialty clinics, and ambulatory surgical centers), across five major regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA)).

Explore Wide-ranging Coverage of Fact.MR’s Healthcare Landscape

Dental Lasers Market: Find insights on the dental lasers market with analysis of segments, statistics, influencers, market players, and business strategies adopted during 2017-2020.

Urology Laser Fibers Market: Fact.MR’s report on the urology laser fibers market offers insights on the market during 2018-2026, including restraints, revenue sources, market leaders, and market strategies.

Surgical Equipment Market: Read an analysis of the surgical equipment market with insights on growth factors, opportunities, restraints, regional market forecast, regulatory policies, and strengths of market leaders.

 

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight:https://www.factmr.com/report/870/alexandrite-gemstone-lasers-market
Press Release:https://www.factmr.com/media-release/1713/global-alexandrite-gemstone-lasers-market

Categories
Pharmaceutical

Pegfilgrastim Biosimilar Market is Expected to Exhibit a CAGR of over 10% by the end of 2026

Award winning market research company Fact.MR has conducted a recent study on the global demand of pegfilgrastim biosimilar market for the upcoming decade. As per its findings, the market is poised to witness impressive growth following increase in cancer cases across the globe. Long-term expansion prospects are expected to remain positive.

Chemotherapy and/or radiotherapy is used for the treatment of most cancers. However, chemotherapy and radiotherapy have a very common side effect called neutropenia, and pegfilgrastim is required for its treatment. A study conducted on patients who received chemotherapy in 2016-2017 to evaluate the occurrence of chemotherapy-induced febrile neutropenia (CIFN) showed that, out of 200 patients, 9.5% patients developed neutropenia. Neutropenia patients are highly susceptible to infections, and for this reason, it is a life-threatening disease.  Pegfilgrastim is advantageous over filgrastim in relatively decreasing the incidence of febrile neutropenia. In the future, pegfilgrastim biosimilars will provide better access to this treatment.

 

Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=1494

 

The pricing of pegfilgrastim biosimilar is around 25% to 30% lower as compared to originator products (i.e. Neulasta by Amgen). Lower prices of pegfilgrastim biosimilars are expected to enhance their adoption for neutropenia treatment in developed as well as developing countries, as multiple regional and global players are seeking to get marketing approval in various countries.

All in all, rising incidence of cancer and increasing use of chemotherapy for treatment will aid the expansion of the pegfilgrastim biosimilar market, which was valued at US$ 944 Mn in 2019, and is expected to exhibit a CAGR of over 10% over the forecast period (2020–2026).

pegfilgrastim biosimilar market

Key Takeaways from Pegfilgrastim Biosimilar Market Study
  • The hospital pharmacies segment under the distribution channel category held half of the global pegfilgrastim biosimilar market share in 2019, owing to increasing cancer treatments such as chemotherapy and others. Retail pharmacies followed due to increasing number of prescriptions.
  • North America holds almost 3/4 of the global pegfilgrastim biosimilar market, followed by Europe, owing to large number of product launches in these regions.
  • The East Asia market year-on-year growth is expected to rapidly surge in the near future. This growth is due to increasing pool of patients and advancements in healthcare with government support, which will propel pegfilgrastim biosimilar market growth in Asian countries.
  • The COVID-19 pandemic that has swept the world is projected to have only a moderate impact on the progress of the pegfilgrastim biosimilar market.

 

Request Methodology & Get a Glimpse of Our Expertise

https://www.factmr.com/connectus/sample?flag=RM&rep_id=1494

“Increasing demand for cost-effective therapeutics such as biosimilars and patent expiration of blockbuster biologics will provide competitive benefits to market players in terms of new product development,”

says a Fact.MR analyst.

Increasing Consolidation among Key Players and New Product Launches

Increase in value chain partnerships and market consolidation activities such as collaborations, partnerships, and M&A among market players will be a significant tool to increase their capabilities and speed to market for new launches. For instance, Mylan and Biocon collaboratively worked on a partnership to launch Pegfilgrastim biosimilar Fulphila.

Manufacturers are making efforts to develop biosimilars, and, so far, in 2020, there were 4 biosimilar launches in the United States, and many more are anticipated to be launched. It is estimated that, the pipeline from 2021 to 2025 will have at least 5 approved biosimilars.

 

Get More Insights- https://www.biospace.com/article/research-on-developing-novel-pegfilgrastim-biosimilars-to-elevate-sales-fact-mr/

 

Looking for More Information?

The research study on the pegfilgrastim biosimilar market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape of the pegfilgrastim biosimilar market over 2018–2019, and includes a detailed assessment of key parameters that are expected to exert influence over 2020–2026. Market statistics have been presented based on distribution channel (hospital pharmacies, retail pharmacies, and mail-order pharmacies), across seven major regions.

 

Explore Fact.MR’s Coverage on the Healthcare Domain

Retinal Biosimilars Market: Fact.MR’s recent study on the global retinal biosimilars offers 10-year forecast. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the drivers, restraints, challenges and opportunities for key market players along with key stakeholders and emerging players.

Fusion Protein biosimilars Market: Fact.MR’s exhaustive analysis on global fusion protein biosimilars market offers value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Oncology Biosimilars Market: Fact.MR has published a detailed research study on the global market for oncology biosimilars. The study provides an in-depth analysis on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the oncology biosimilars market structure.

 

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight:https://www.factmr.com/report/1494/pegfilgrastim-biosimilar-market
Press Release: https://www.factmr.com/media-release/1690/global-pegfilgrastim-biosimilar-market

Categories
Pharmaceutical

Covid-19: Impact on Radiochemical Synthesizers Market Statistics 2021-2031: Innovation and Product Optimization to Boost Growth

Fact.MR has used a versatile approach to focus attention on the historical evolution, sales and demand of Radiochemical Synthesizers Market. Drivers and constraints, threats and opportunities, regional segmentation and opportunity assessment, end-use/application prospects review, and competitive landscape assessment are just a few of the topics addressed in the Global Radiochemical Synthesizers Market report.

Radiochemical synthesizers make chemical products which include small portions of radioisotopes by irradiating a selected target which are found inside a nuclear research reactor or in a particle accelerator. When such radioisotopes are produced, these are tagged on certain molecules based on biological capabilities which leads to Radiotherapy.

Request For Sample Report: https://www.factmr.com/connectus/sample?flag=B&rep_id=5632

Competitive Landscape

Some of the major players in the global Radiochemical Synthesizers Market are Mercurius Health, IBA, Elysia, IAEA, Advion, Inc, Advanced Cyclotron Systems, JSC Isotope, Lantheus Medical Imaging, Inc., BV Cyclotron VU, LabLogic Systems Ltd, NorthStar Medical Technologies Technological advancement in already marketed products, which is the major trend emerging in the global Radiochemical Synthesizer Market.

Key Segments of Radiochemical synthesizers Market Covered in the Report

Based on Product, the global Radiochemical Synthesizers Market is segmented as:

  • Cyclotron
  • Nuclear Reactor
  • Radionuclide generator

Based on indications, the global Radiochemical Synthesizers Market is segmented as:

  • Cancer Treatment
  • Neurology
  • Cardiology

Based on end user, the global Radiochemical Synthesizers Market is segmented as:

  • Hospitals
  • Pharmaceutical Companies
  • Academic and Research centres

Request Customized Report as Per Your Requirements –

https://www.factmr.com/connectus/sample?flag=RC&rep_id=5632

Will the Market of U.S. is Larger than that of Asia?

The U.S. is holding largest share in the market attributing to the existence of a large population affected with chronic diseases like coronary disorders, cancer, unhealthy lifestyles, and increasing R&D for effective and reduced side effects treatment. As per the National Cancer Institute, in 2020, around 4.5 million cases of cancer were diagnosed in the US. The rise in the research & development (R&D) and the existence of the leading players in the market will boost the Radiochemical synthesizer’s market growth.

The Growing investment for research and the presence of a huge patient pool and the presence of developed economies such as Germany, the UK, and France are expected to drive the growth of the market. Europe is expected to be the second largest market after U.S.

Share Your Requirements & Get Customized Reports : https://www.factmr.com/checkout/5632

Report Benefits & Key Questions Answered

  • Radiochemical Synthesizers Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Radiochemical Synthesizers Historical volume analysis: The report provides a comparison of Radiochemical Synthesizers historical sales and projected sales performance for 2021-2031.
  • Radiochemical Synthesizers Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Radiochemical Synthesizers market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Radiochemical Synthesizers Consumption by demographics: The report investigates consumer behaviour affecting Radiochemical Synthesizers demand outlook for the assessment period. Effect of their keenness for digital trends on Radiochemical Synthesizers market is carefully analysed
  • Post COVID consumer spending on Radiochemical Synthesizers: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analysed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Radiochemical Synthesizers market growth.

Explore Fact.MR’s Coverage on the Healthcare Domain

Single-Dose Radiotherapy Market: Fact.MR’s ongoing research project on the single-dose radiotherapy market delves into detailed observations regarding the prominent expansion prospects expected to present themselves throughout the forthcoming decade.

Image Guided Radiotherapy Market: The global image guided radiotherapy market is likely to escalate to new heights, amid rising prevalence of various respiratory disorders, according to an ongoing study on the market by Fact.MR.

Radiotherapy Devices Market: Fact.MR’s incumbent study on the radiotherapy devices market brings to the fore important growth dynamics which are expected to shape future expansion trajectory for the decade until 2031.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

 Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

COVID-19 Impact on Lung Monitoring Devices Market Set for Rapid Growth and Trend, by 2031

Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the Lung Monitoring Devices Market during the historical period. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2031, and key prospects over the forecast period 2021 – 2031. The insights and analytics on the Lung Monitoring Devices Market span several pages. These are covered in numerous sections, including, drivers and restraints, challenges and opportunities, regional segmentation and opportunity assessment, end-use/application prospects analysis, and competitive landscape assessment.

To get In-depth Insights Request for Free Brochure here : https://www.factmr.com/connectus/sample?flag=B&rep_id=5670

Respiration is an irreplaceable human life cycle, beginning at the time of birth and continuing up until death. For lots of years, a healthy body has actually had the ability to breathe, however due to increasing levels of contamination in cosmopolitan cities and way of lives including smoking, obstructing of respiratory tracts and other lung structures, it is ending up being an around the world concern.

Lung monitoring systems are devices that provide medication to prevent and handle signs and assistance reduce worsenings of several lung conditions such as persistent obstructive lung illness (COPD) and asthma. Lung monitoring devices might consist of either a single or a mix of drugs, such as a bronchodilator, a corticosteroid, a mix of various bronchodilator or corticosteroid respectively.

More than 1 billion individuals around the world are impacted by persistent breathing illness, based on the 2018 Global Asthma Survey. One of the primary factors to this fact is asthma, which impacts babies, grownups, and senior individuals.

Key Segments of Lung Monitoring Devices Market Covered in the Report

Based on type of device, the lung monitoring devices market has been segmented as:

  • Spirometers
  • Pulse Oximeters
  • Peak Flow Meters
  • Sleep Test Devices
  • Gas Analyzers
  • Capnographs
  • Other Types of Devices

Pre-Book Right Now for Exclusive Analyst Support: https://www.factmr.com/checkout/5670

Based on end user, the lung monitoring devices market has been segmented as:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Homecare Settings

Based on the region, the lung monitoring devices market has been segmented as:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5670

Competitive Landscape Analysis

  • DeVilbiss Healthcare LLC
  • Koninklijke Philips N.V.
  • Vitalograph Ltd
  • ResMed Inc.
  • Haag-Streit group
  • Medline Industries Inc.
  • Trudell Medical International
  • Teleflex Inc.
  • Omron Healthcare Co Ltd.
  • Rossmax International Ltd.
  • Vyaire Medical Inc.
  • nSpire Health Inc.

Hence, the demand for smart peak flow meters can increase in the future, which can ultimately increase the growth of the lung monitoring devices market at a higher rate.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/melanoma-cancer-diagnostics-market-to-rely-on-fish-and-ai-for-future-expansion-fact-mr/

Explore Fact.MR’s Coverage on the Healthcare Domain:

 Next Generation Patient Monitoring Devices Market– The global demand for next-generation patient monitoring devices witnessed major rise in Covid-19 pandemic due to the rising focus on health and well-being amongst the people in 2020.

Continuous Cardiac Monitoring Systems Market- Continuous cardiac monitoring systems market is estimated to observe a slight increase in demand amid pandemic with an increasing number of Covid 19 patients.

Ambulatory heart Monitor Market- The global ambulatory heart monitor market is anticipated to grow with the rising cardiovascular diseases, expanding geriatric population, high demand for ambulatory heart monitors for its utility, efficacy and cost-effectiveness and technological enhancements.

 About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

 Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Lip Filler Market Share to Gain a Stronghold during Forecast Period Till 2026

Fact.MR, a global research firm, in its recent report on the global lip filler market shall register a steady CAGR in 2021 & beyond. Rise in number of aesthetic procedures and increasing payment options to boost the aesthetic procedure pace are contributing to the expansion of the industry. Also, improvements in the preparation procedure of lip fillers have prompted a higher need for lip procedures.

The market survey of Lip Filler offers a comprehensive analysis of diverse features, including production capacities analysis of Lip Filler, demand, product developments, revenue generation, and sales of Lip Filler across the globe.

For detailed insights on enhancing your product footprint, request for a brochure here: https://www.factmr.com/connectus/sample?flag=B&rep_id=864

Competitive Landscape Analysis

 Some of the key players are Mentor Worldwide LLC, Anika Therapeutics Inc., Allergan Plc, and Inamed Corporation, etc.

The growing investments in research and development of cosmetic industry have been encouraging the prominent players to offer effective solutions to gain a competitive edge.

 Merz Aesthetics: The prominent player in lip filler market, Merz Aesthetics launched a new a lip filler with hyaluronic acid called Belotero lips in April 2018.

  • Galderma: The Pharmaceutical Company launched two new dermal fillers last year. In December 2016, Galderma got FDA approval for: Restylane Refyne and Restylane Defyne, its two next-generation hyaluronic acid (HA) dermal fillers. The brand calibrated the products for smoothness and consistent textures, delivering dual benefit of flexibility and distributed product integration.

Segmentation:

The global market for lip filler can be classified on the basis of product type, and end users. By product type, it can be bifurcated into Hyaluronic Acid based products, and Collagen based products, whereas, in terms of end users, the market can be segmented into hospitals and specialty clinics.

Request Customized Report as Per Your Requirements –

https://www.factmr.com/connectus/sample?flag=RC&rep_id=864

Key Developments in Lip Filler Market

In November 2020, Aesthetic innovations announced its partnership with Merz Aesthetics to launch National Xeomin Campaign for their new product line, Xeomin. The development is a mobile video technology that records the customer’s end to end experience. The company is looking forward to customise and improve customer experience via mobile video without apps, or logins or email, etc.

Suneva medical in May 2020 announced that it is all set to increase its partnership and leadership in aesthetic with Sinclair Pharma’s new launch, Silhouette Instalift. The launch is likely to address the growing demand for natural alternatives in aesthetics. The product provides immediate lift to sagging cheeks and activates the patient’s natural collagen production over time.

Pre-Book Right Now for Exclusive Analyst Support: https://www.factmr.com/checkout/864

A Switzerland based company Gladerma in May 2020 announced the results of their newly launch treatment DREAM (Dysport Real- World Evaluation and Measured satisfaction study). The treatment is 95% efficient with two treatments per year and 97% of patients felt the look natural after treatment. Dysport is an injection for removing the severe frown lines between the eyebrows in adults aging less than 65 years.

Social media is overflowing with airbrushed pictures of celebrities with perfectly groomed bodies staged in exotic locations, and such impeccable photographs are pressurizing youngsters to meet unattainable body-image standards. In the race to look flawless, growing number of people are spending on cosmetic treatments like lip fillers, Botox etc.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/03/03/1994330/0/en/Sterile-Active-Pharmaceutical-Ingredients-Market-Set-for-Robust-Growth-Through-2029-Injectable-Drugs-in-Demand-Reports-a-Fact-MR-Study.html

Explore Fact.MR’s Healthcare Reports

Hospital Asset Management Market: Delve into Fact.MR’s extensive study on the hospital asset management market, offering detailed assessment. The study analyses crucial trends that are currently determining, and those which are expected to shape future expansion trajectory, shedding light on the vital dynamics such as drivers, restraints and opportunities.

Aneurysm Clips Market: The global aneurysm clips market study published by Fact.MR incorporates detailed assessment of the market landscape, taking into consideration value chain analysis, business execution and supply chain analysis across key markets.

Aptamers Market: Fact.MR’s global aptamers market research report provides stakeholders with an exhaustive analysis on key market dynamics, such as the drivers, restraints, opportunities and trends responsible for shaping the future expansion trajectory.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

North America Accounting for 34% of the Upper Extremity Prosthetics Market Share by 2025

Fact.MR, in its exclusive research report on the artificial limbs market, highlights actionable insights and winning imperatives for stakeholders.

This comprehensive study unfolds rare and distinguished intelligence regarding impactful dynamics, which directly or indirectly influence the growth of artificial limbs during the forecast period (2020 – 2025).

With the help of crucial insights discussed in this study, stakeholders will gain a thorough idea regarding the growth trajectory of the artificial limbs market.

Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4359

Mind-controlled humonic solutions are a radical breakthrough in research related to artificial limbs. These solutions can restore the unmet needs of lost sensation and human-like aesthetics, including gestures and volitional control. Extensive research in the field of artificial intelligence aimed at better quality of life for amputees is fuelling the growth of the artificial limbs market. Fact.MR, in its newest report, reveals that, the Sales of artificial limbs is all set to witness a healthy CAGR of 6% through the forecast period (2020 – 2025).

Artificial Limbs Market – Assessment of Key Segments

Product
  • Upper Extremity
  • Lower Extremity
  • Sockets
  • Liners
  • Others
Technology
  • Cosmetic Prosthetics
  • Cable-operated/Battery-powered Prosthetics
  • Electrically-powered/Myoelectric Prosthetics
End User
  • Hospitals
  • Prosthetic Clinics
  • Rehabilitation Centres
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Get Customization on this Research Report for specific research solutions:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=4359

Key Takeaways of Artificial Limbs Market

• Lower extremity prosthetics accounted for 55% share of the market in 2019, owing to the high prevalence of diabetes and vascular diseases across the globe.
• Electrically-powered/myoelectric prosthetics are projected register the fastest growth by the end of the forecast period. Advancements such as multi-articulating myoelectric hands are estimated to fuel this growth.
• According to Fact.MR, hospitals and prosthetic clinics will collectively account for 75% of the market share by the end of the forecast year. An uptick in the demand for prosthetics for trauma injuries and amputations during military combat will bolster the growth of these segments.
• North America will lead the artificial limbs market by the end of the forecast period. However, Asia Pacific will witness prolific growth, on the back of a surging geriatric population and an alarming high incidence of accidents.

For information on the Research Approach used in the Report, Request Methodology

https://www.factmr.com/connectus/sample?flag=RM&rep_id=4359

artificial limbs market regional opportunity assessment

“Clinical service networks, strong clinical teams, high focus on the marketing of products, and market diversification will be the key tenets of success for market players operating in the artificial limbs market”, says a Fact.MR Analyst.

Product Innovations and Well-timed Partnerships Lead to a Top-Heavy Competition Landscape
The artificial limbs market is highly consolidated in nature, with Ossur, Ottobock, and Hanger among the key players. Leading players have established a strong foothold in the market through strong teams, innovation, a highly-nuanced product portfolio, and timely acquisitions. For instance,
• In November 2019, Ossur and Alfred Mann Foundation (AMF) signed a milestone agreement that allows Ossur to further develop and licence AMF’s implanted myoelectric sensor systems, as both these organizations surge ahead to explore the potential of mind-controlled prosthetic technologies.
• In the same month, Ottobock announced advancements in upper limb prosthetics, called the Myo Plus pattern recognition system. Ottobock partnered with Hanger to fit this new design onto an amputee. The technology has been approved and cleared by the FDA.

Fore More Insights

https://www.biospace.com/article/cell-proliferation-market-players-are-relying-on-partnerships-and-alliance-to-speed-up-r-and-d-study/

Key Players 

  • Össur
  • Hanger, Inc.
  • Ohio Willow Wood Company
  • Ottobock
  • RSL Steeper Group Ltd.
  • PROTEOR
  • Blatchford Group
  • Liberating Technologies, Inc.
  • Fillauer LLC
  • Spinal Technology, Inc.
  • Optimus Prosthetics

Find More Valuable Insights on Artificial Limbs Market

The research study on the artificial limbs market by Fact.MR incorporates an unbiased assessment of the key demand-driving factors and trends that can shaped the landscape of artificial limbs over 2020 – 2025, and includes a detailed assessment of the key parameters that are anticipated to exert influence over the forecast period. Market statistics have been presented on the basis of product (upper extremity, lower extremity, sockets, liners, others), technology (cosmetic prosthetics, cable-operated/body-powered prosthetics, electrically-powered/myoelectric prosthetics, others), end user (hospitals, prosthetic clinics, rehabilitation centres), across five major regions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com